Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kozo Morimoto

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Annals of the American Thoracic Society|April 9, 2021
Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective StudyKazuma Yagi, Akihiro Ito, Keiji Fujiwara, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass IndexKyungtaek Park, Hyejin Kim, Hee Jae Huh, et al.
Respiratory Medicine|December 5, 2018
Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RITKozo Morimoto, Taku Nakagawa, Takahiro Asami, et al.
Pulmonology|February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic reviewDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Annals of the American Thoracic Society|March 31, 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trialCharles L Daley, Jakko van Ingen, James D Chalmers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Auris, Nasus, Larynx|March 27, 2024
Practical guide for the diagnosis and management of primary ciliary dyskinesiaKazuhiko Takeuchi, Miki Abo, Hiroshi Date, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by David E Griffith, Gina Eagle, Rachel Thomson, et al.
The European Respiratory Journal|February 5, 2021
Genome-wide association study in patients with pulmonary <i>Mycobacterium avium</i> complex diseaseHo Namkoong, Yosuke Omae, Takanori Asakura, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Annals of the American Thoracic Society|April 9, 2021
Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective StudyKazuma Yagi, Akihiro Ito, Keiji Fujiwara, et al.
American Journal of Respiratory and Critical Care Medicine|September 12, 2025
Novel Genetic Loci for Nontuberculous Mycobacterial Pulmonary Disease and Potential Protective Effect of Body Mass IndexKyungtaek Park, Hyejin Kim, Hee Jae Huh, et al.
Respiratory Medicine|December 5, 2018
Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RITKozo Morimoto, Taku Nakagawa, Takahiro Asami, et al.
Pulmonology|February 24, 2026
Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic reviewDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
The European Respiratory Journal|November 6, 2025
Consensus on the management of refractory nontuberculous mycobacterial pulmonary diseaseDiana Moreira-Sousa, Beatriz Martins, Ana Aguiar, et al.
Annals of the American Thoracic Society|March 31, 2026
Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trialCharles L Daley, Jakko van Ingen, James D Chalmers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2020
Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel SurveyJakko van Ingen, Stefano Aliberti, Claire Andrejak, et al.
Auris, Nasus, Larynx|March 27, 2024
Practical guide for the diagnosis and management of primary ciliary dyskinesiaKazuhiko Takeuchi, Miki Abo, Hiroshi Date, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2018
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by David E Griffith, Gina Eagle, Rachel Thomson, et al.
The European Respiratory Journal|February 5, 2021
Genome-wide association study in patients with pulmonary <i>Mycobacterium avium</i> complex diseaseHo Namkoong, Yosuke Omae, Takanori Asakura, et al.
Pageof 20